Today’s time-consuming diagnostics of sepsis leads to an unnecessary amount of hospital days and an overuse of broad spectrum antibiotics. Q-linea´s fully automated solutions will enable healthcare providers to accurately diagnose sepsis in the shortest possible time. Our analysis platforms will drastically reduce the time for sepsis diagnosis.

ASTar™ will deliver answers about antibiotic susceptibility within three to six hours directly from positive blood cultures. The ASTrID® platform will identify the cause of sepsis directly from venous blood and deliver an antibiotic susceptibility profile in ten hours. Both systems will report true minimal inhibitory concentration values.

Rapid AST directly from blood culture

ASTar™ is a fully automated, "load-and-go", instrument for Antibiotic Susceptibility Testing (AST), giving a susceptibility profile within three to six hours directly from a positive blood culture. ASTar shortens time to result, enabling early use of antibiotics specifically targeting the disease-causing pathogen.

Read more about ASTar »

Sepsis diagnostics in hours instead of days

Sepsis is a disease growing in prevalence – early discovery and diagnostics will be key to its management. By using a technology that eliminates the need for traditional blood cultures the ASTrID® platform will shorten the current lead times in sepsis treatment by several days. The ASTrID platform is currently under development.

Read more about ASTrID »

Q-linea was part of the closing bell ceremony on December 6th at Nasdaq NYC

Q-linea was part of the closing bell ceremony on Wednesday 6th of December at Nasdaq NYC together with Carnegie (the Nordic regions number 1 investment bank). Q-linea was presenting… Read more

Read more

Q-linea at J.P Morgan annual conference, January, 2018

Meet us at the 36th annual J.P Morgan healthcare conference, January 8-11, in San Francisco, California.  

Read more

Meet us at ECCMID 2018 in Madrid

Booth no 47, April 21-24 in Feria de Madrid. Please join us at the meeting, and take the chance to talk to our representatives about or new system,… Read more

Read more